CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.
January 31st 2023
Patients with refractory metastatic colorectal cancer often don’t have many effective treatment options, although immunotherapy may be a promising potential for patients based on recent study findings.
January 27th 2023
From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.
January 25th 2023
Patients with pretreated metastatic colorectal cancer had better outcomes when Avastin was added to their Lonsurf treatment in the third line setting.
January 24th 2023
The FDA recently approved a combination treatment for patients with previously treated metastatic colorectal cancer with HER2-positive disease determined by biomarker testing.
January 23rd 2023
I recently met another woman with Lynch syndrome, the same hereditary cancer syndrome that I have, and it made me reflect on the steps I was taking to maintain my health.
January 21st 2023
The multicenter study is evaluating the safety and efficacy of nanrilkefusp alfa combined with Erbitux.
January 19th 2023
The FDA approved Tukysa plus Herceptin for previously treated patients with HER2-positive metastatic colorectal cancer.
January 18th 2023
The COVALENT-102 trial will investigate BMF-219 in patients with non-small cell lung cancer, colorectal and pancreatic cancers.
January 18th 2023
A test that measures tumor DNA in the blood could be a helpful prognostic factor in patients with colorectal cancer who underwent surgery.
January 10th 2023
Treatments before surgery for rectal adenocarcinoma, a type of rectal cancer, have increased and correlated with preservative surgeries and improved overall survival in the last 16 years, though improvements may still be needed for disease screening, an expert said.
January 5th 2023
I’ve heard the phrase, “don’t waste your cancer,” as a way to encourage survivors to tell their stories and donate to nonprofits.
December 30th 2022
Exercising moderately every week has been linked to improved disease outcomes at any BMI in patients with colorectal cancer.
December 29th 2022
Pelé died on Dec. 29, 2022, from complications related to his colon cancer.
December 9th 2022
From the death of a Broadway actor to TV stars completing treatment, here’s what’s happening in the cancer space this week.
November 1st 2022
Recent research unveiled groups of patients with colorectal cancer who should undergo more frequent scans to detect disease that has spread to the lungs.
September 27th 2022
The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.
September 20th 2022
The Food and Drug Administration granted a priority review for Tukysa plus Herceptin for patients with pretreated, metastatic colon cancer.
September 18th 2022
Despite my mother and grandmother’s history with the disease, I never thought I would one day receive a colon cancer diagnosis.
September 15th 2022
As I face the end of my life due to metastatic colorectal cancer, I’m preparing my loved ones for my death — from determining who gets my stuff to writing my eulogy and making my memorial service playlist.
September 8th 2022
The first patient was treated in a phase 2 trial assessing the safety and efficacy of navicixizumab, with or without chemotherapy, in colorectal, gastric, ovarian and breast cancer.
August 31st 2022
Patients with early-stage rectal cancer may be able to forego major surgery — thus preserving their organs and quality of life — with a pre-surgical chemotherapy regimen, according to recent study results.
August 30th 2022
Researchers developed an artificial intelligence algorithm to potentially improve the prediction of colon cancer recurrence, which may help patients receive the appropriate treatment.
August 26th 2022
Many participants enrolled in the CRC-PREVENT trial are from communities often underrepresented in clinical trials due to gender, race and socioeconomic status, among other factors.
August 18th 2022
Investigators plan to analyze if treatment with an experimental, CAR-T cell therapy is safe and effective in a small group of patients with relapsed or refractory metastatic colorectal cancer.
August 16th 2022
A new study will analyze the effect of exercise on chemotherapy tolerability and outcomes in patients with colon cancer.
August 15th 2022
The researchers hypothesize that treatment with the investigational drug combined with chemoradiotherapy may reduce the need for invasive surgery to remove the rectum and surrounding tissue in this patient population.
July 13th 2022
The manufacturer of one of the cancer treatments announced that it is also participating in clinical trials assessing the safety and efficacy of their product in colorectal and endometrial cancer.
July 6th 2022
In a clinical trial, the use of Tukysa plus Herceptin demonstrated promising results in treating patients with HER2-positive metastatic colorectal cancer.
June 8th 2022
One-hundred percent of patients with stage 2/3 mismatch repair-deficient rectal cancer had their disease disappear after treatment with Jermperli, though more research and longer follow-up is needed.